Peripheral IV Catheters Market Size, Share, Growth, and Industry Analysis, By Type (Safety, Conventional), By Application (Hospitals, ASC, Clinics, Home Healthcare, Others), Regional Insights and Forecast to 2034

Peripheral IV Catheters Market Overview

The Peripheral IV Catheters Market size was valued at USD 4474.08 million in 2025 and is expected to reach USD 6291.99 million by 2034, growing at a CAGR of 3.5% from 2025 to 2034.

The Peripheral IV Catheters Market is witnessing strong expansion due to increasing hospitalization rates, rising chronic disease prevalence, and growing surgical procedures globally. More than 85% of hospitalized patients required peripheral intravenous access during treatment in 2025. Safety peripheral IV catheters accounted for approximately 62% of total catheter utilization because of rising needlestick injury prevention measures and infection control standards. Around 71% of emergency departments integrated closed catheter systems to reduce bloodstream infection risks. The Peripheral IV Catheters Market Report highlights that hospitals represented nearly 58% of total product demand in 2025, while home healthcare applications exceeded 14% share due to increasing outpatient care trends.

The USA Peripheral IV Catheters Market Analysis shows that the United States accounted for approximately 33% of global peripheral IV catheter consumption during 2025. More than 200 million peripheral IV catheter procedures were performed annually across hospitals and ambulatory care facilities in the country. Around 69% of U.S. hospitals adopted safety-engineered peripheral IV catheters to comply with occupational safety standards and infection prevention protocols. Approximately 41% of emergency room admissions required intravenous catheter insertion within the first hour of treatment. In addition, nearly 52% of outpatient infusion therapy centers integrated advanced peripheral IV catheter stabilization systems to improve patient safety and reduce catheter dislodgement rates.

• 

  Download Free sample to learn more about this report.

Key Findings

• Key Market Driver:More than 74% of hospitalized patients required intravenous therapy, while approximately 63% of healthcare facilities adopted safety peripheral IV catheters and nearly 48% of emergency departments increased catheter utilization for rapid treatment procedures.
• Major Market Restraint:Approximately 42% of healthcare providers reported catheter-related complications, while 36% experienced accidental dislodgement issues and nearly 31% identified bloodstream infection risks associated with improper catheter insertion and maintenance procedures.
• Emerging Trends:Around 58% of hospitals adopted closed IV catheter systems, while approximately 47% of healthcare providers integrated antimicrobial-coated catheters and nearly 39% of outpatient centers expanded home-based infusion therapy services during 2025.
• Regional Leadership:North America accounted for approximately 38% of global peripheral IV catheter utilization, while Europe represented nearly 27% of safety catheter adoption and Asia-Pacific contributed approximately 29% of healthcare facility expansion activities.
• Competitive Landscape:The top 10 peripheral IV catheter manufacturers controlled approximately 67% of global supply activities, while integrated medical device companies accounted for nearly 59% of safety catheter production and hospital distribution operations.
• Market Segmentation:Safety peripheral IV catheters represented approximately 62% of total market demand, while conventional catheters accounted for nearly 38%, with hospitals contributing 58%, clinics 14%, and home healthcare approximately 14%.
• Recent Development:During 2025, approximately 44% of healthcare institutions upgraded to needle-free catheter systems, while nearly 36% of manufacturers launched antimicrobial-coated peripheral IV catheters to improve infection prevention and patient safety.

Peripheral IV Catheters Market Latest Trends

The Peripheral IV Catheters Market Trends indicate increasing adoption of safety-engineered catheters and needle-free intravenous access systems across hospitals and outpatient facilities. More than 72% of acute care hospitals integrated closed peripheral IV catheter systems during 2025 to reduce catheter-related bloodstream infection risks and improve healthcare worker safety. Around 49% of healthcare facilities implemented antimicrobial-coated catheter technologies to minimize contamination and bacterial growth during long-duration intravenous therapy.

Home healthcare emerged as a major trend in the Peripheral IV Catheters Market Research Report. Approximately 34% of outpatient infusion procedures were performed in home-based healthcare settings during 2025, increasing demand for easy-to-use peripheral IV catheters with improved stabilization mechanisms. Around 46% of ambulatory surgical centers integrated advanced catheter securement systems to reduce accidental catheter dislodgement rates.

Technological advancements also accelerated market development. Approximately 41% of newly launched peripheral IV catheters included passive needle protection mechanisms to reduce needlestick injuries. Ultrasound-guided catheter insertion procedures increased by nearly 27% between 2023 and 2025 in emergency and critical care units. The Peripheral IV Catheters Industry Analysis highlights increasing demand from geriatric populations, chronic disease management programs, and outpatient infusion therapy services as major contributors to market expansion during 2025.

Peripheral IV Catheters Market Dynamics

DRIVER

Rising hospitalization and intravenous therapy procedures.

The Peripheral IV Catheters Market Growth is strongly driven by increasing hospitalization rates and rising demand for intravenous therapy procedures worldwide. More than 85% of hospitalized patients required peripheral IV catheter insertion during treatment in 2025 for medication administration, hydration, blood transfusion, and emergency care applications. Around 61% of chronic disease patients undergoing long-term treatment required repeated intravenous access procedures. Emergency departments increased peripheral IV catheter utilization by approximately 43% between 2023 and 2025 due to growing trauma, cardiac, and critical care admissions. In surgical settings, nearly 78% of inpatient procedures required intravenous catheter placement for anesthesia and fluid management. Additionally, approximately 54% of healthcare facilities upgraded to safety-engineered peripheral IV catheters to improve occupational safety and reduce healthcare-associated infection risks.

RESTRAINT

Catheter-related infections and complications.

The Peripheral IV Catheters Industry Report identifies catheter-related complications as a major restraint affecting market growth. Approximately 42% of healthcare providers reported incidents involving phlebitis, infiltration, or catheter occlusion during peripheral IV therapy procedures. Around 36% of hospitals experienced accidental catheter dislodgement issues, increasing treatment delays and replacement procedures. Bloodstream infection risks remained a significant concern, with nearly 31% of healthcare institutions strengthening infection prevention protocols between 2023 and 2025. Approximately 28% of patients receiving prolonged intravenous therapy experienced localized skin irritation or vascular complications associated with catheter placement. In addition, around 24% of healthcare facilities faced higher training requirements for advanced catheter insertion technologies and ultrasound-guided procedures. These factors continue to influence clinical efficiency and product adoption patterns across the Peripheral IV Catheters Market.

OPPORTUNITY

Expansion of outpatient and home healthcare services.

The Peripheral IV Catheters Market Opportunities are increasing because of expanding outpatient infusion therapy and home healthcare services globally. Approximately 39% of healthcare systems shifted non-critical intravenous therapy procedures toward outpatient and home-based treatment settings during 2025. Around 47% of ambulatory care centers integrated advanced peripheral IV catheter stabilization devices to improve patient mobility and therapy continuity. Home infusion therapy utilization increased by nearly 32% between 2023 and 2025, particularly among oncology, antibiotic therapy, and chronic disease patients. In Asia-Pacific, approximately 36% of newly established outpatient treatment facilities adopted safety peripheral IV catheters for short-term infusion procedures. Healthcare digitization and remote patient monitoring systems also improved outpatient intravenous therapy management, with nearly 21% of healthcare providers integrating smart infusion tracking technologies. The Peripheral IV Catheters Market Outlook remains favorable due to increasing preference for minimally invasive outpatient treatment solutions.

CHALLENGE

Product standardization and healthcare cost pressure.

One of the major challenges in the Peripheral IV Catheters Market Forecast is maintaining product standardization while managing healthcare cost constraints. Approximately 38% of healthcare facilities reported procurement challenges linked to varying catheter specifications and compatibility issues with infusion systems. Around 33% of smaller clinics and outpatient centers experienced budget limitations affecting adoption of advanced safety catheter technologies. Product recalls and regulatory compliance issues impacted approximately 17% of peripheral IV catheter distribution activities between 2023 and 2025. In developing economies, nearly 29% of healthcare providers relied on conventional catheter systems due to lower procurement costs and limited reimbursement coverage. Additionally, around 26% of hospitals faced supply chain delays affecting catheter inventory management and emergency care operations. These factors continue influencing purchasing decisions and product adoption across global healthcare systems.

• 

  Download Free sample to learn more about this report.

Peripheral IV Catheters Market Segmentation Analysis

The Peripheral IV Catheters Market Size is segmented by type and application across hospitals, ambulatory surgical centers, clinics, home healthcare, and specialty healthcare facilities. Safety peripheral IV catheters accounted for approximately 62% of total market demand during 2025 due to rising focus on healthcare worker safety and infection prevention protocols. Conventional peripheral IV catheters represented nearly 38% share because of continued utilization in low-cost healthcare environments. By application, hospitals contributed approximately 58% of total peripheral IV catheter utilization, while ambulatory surgical centers accounted for nearly 11%, clinics represented approximately 14%, home healthcare maintained 14%, and other healthcare applications contributed around 3% share across the global Peripheral IV Catheters Market.

By Type

Safety

Safety peripheral IV catheters represented approximately 62% of the Peripheral IV Catheters Market Share in 2025 due to increasing implementation of needlestick injury prevention regulations and infection control measures. More than 69% of hospitals across North America and Europe adopted passive safety-engineered catheter systems to improve healthcare worker protection during intravenous access procedures. Around 53% of emergency departments integrated needle-free catheter technologies to reduce accidental blood exposure risks. Antimicrobial-coated safety catheters reduced catheter-related infection risks by approximately 24% in critical care applications. In Asia-Pacific, nearly 41% of newly established healthcare facilities integrated safety catheter technologies between 2023 and 2025. The Peripheral IV Catheters Market Analysis highlights increasing utilization in intensive care units, oncology infusion therapy, and outpatient treatment centers because of enhanced patient safety and improved clinical efficiency.

Conventional

Conventional peripheral IV catheters accounted for nearly 38% of the global Peripheral IV Catheters Market in 2025 because of lower procurement costs and widespread utilization in developing healthcare systems. Approximately 57% of smaller clinics and community healthcare centers in low-income regions continued using conventional IV catheters due to budget constraints and limited reimbursement support. Around 44% of short-term intravenous therapy procedures in rural healthcare facilities utilized conventional catheter systems for medication administration and hydration therapy. Conventional peripheral IV catheters remained common in approximately 32% of outpatient emergency care settings because of rapid insertion capability and low operational cost. The Peripheral IV Catheters Market Research Report indicates that demand for conventional catheters remains stable across cost-sensitive healthcare environments and high-volume emergency treatment applications.

By Application

Hospitals

Hospitals accounted for approximately 58% of the global Peripheral IV Catheters Market Share in 2025 due to high patient admissions, emergency procedures, and inpatient intravenous therapy requirements. More than 88% of hospitalized patients required peripheral IV catheter insertion for medication delivery, blood transfusion, hydration, or anesthesia administration. Around 64% of intensive care units adopted safety peripheral IV catheters with closed-system technology to reduce bloodstream infection risks and improve patient safety. Emergency departments represented approximately 39% of hospital-based catheter utilization because of increasing trauma, cardiac, and surgical admissions. In developed healthcare systems, nearly 71% of hospitals integrated needle-free IV catheter systems to reduce healthcare worker needlestick injuries. The Peripheral IV Catheters Market Insights identify increasing chronic disease hospitalization and aging population growth as major contributors to hospital catheter demand.

ASC

Ambulatory surgical centers (ASC) represented approximately 11% of the Peripheral IV Catheters Market Size in 2025 because of increasing same-day surgical procedures and minimally invasive treatment adoption. Around 52% of outpatient surgical procedures performed in ASCs required peripheral intravenous catheterization for anesthesia administration and medication delivery. Approximately 46% of ambulatory care facilities adopted safety peripheral IV catheter systems to improve procedural efficiency and patient throughput. In North America, nearly 37% of outpatient orthopedic and gastrointestinal procedures utilized advanced catheter stabilization technologies to reduce insertion complications and improve treatment continuity. Ultrasound-guided IV insertion procedures in ASCs increased by approximately 19% between 2023 and 2025 due to growing patient complexity and shorter procedural turnaround times. The Peripheral IV Catheters Market Report highlights rising outpatient surgery volumes as a key factor supporting catheter utilization in ambulatory care settings.

• 

  Download Free sampleto learn more about this report.

Peripheral IV Catheters Market Regional Outlook

North America

North America accounted for approximately 38% of the global Peripheral IV Catheters Market Share in 2025 because of advanced healthcare infrastructure, high hospitalization rates, and widespread adoption of safety-engineered catheter systems. More than 200 million peripheral IV catheter insertions were performed annually across hospitals and ambulatory care facilities in the United States and Canada. Approximately 74% of healthcare facilities in the region adopted safety peripheral IV catheters to comply with occupational safety and infection prevention regulations.

The United States represented nearly 83% of regional market demand. Around 69% of hospitals integrated needle-free catheter systems to reduce healthcare-associated infections and needlestick injuries. Emergency departments accounted for approximately 41% of total peripheral IV catheter utilization in U.S. hospitals because of rising trauma, cardiovascular, and critical care admissions. Nearly 58% of outpatient infusion therapy providers adopted advanced catheter stabilization systems between 2023 and 2025.

Europe

Europe represented approximately 27% of the global Peripheral IV Catheters Market Size in 2025 because of strong infection prevention regulations, advanced healthcare systems, and increasing outpatient treatment procedures. Germany, France, the United Kingdom, and Italy collectively accounted for nearly 71% of regional peripheral IV catheter utilization. Around 67% of hospitals across Europe integrated safety peripheral IV catheter systems to comply with occupational safety directives and bloodstream infection prevention standards.

Germany represented approximately 29% of regional market demand due to high hospitalization rates and advanced surgical care infrastructure. More than 52% of German hospitals adopted closed peripheral IV catheter systems to reduce contamination risks during intravenous therapy procedures. France accounted for nearly 19% of regional demand because of increasing outpatient infusion therapy and oncology treatment services. The United Kingdom contributed approximately 17% of market utilization through expanded emergency care and ambulatory surgery activities.

Asia-Pacific

Asia-Pacific accounted for approximately 29% of the global Peripheral IV Catheters Market Share in 2025 because of rapid healthcare infrastructure expansion, increasing patient admissions, and rising healthcare investments. China, India, Japan, and South Korea collectively represented nearly 76% of regional peripheral IV catheter consumption. More than 61% of newly established hospitals in Asia-Pacific integrated safety peripheral IV catheter systems during 2025 to improve infection prevention and healthcare worker safety.

China represented approximately 38% of regional market demand because of high patient volumes and expanding hospital infrastructure. Around 72% of tertiary care hospitals in China utilized peripheral IV catheter systems for emergency care, surgical procedures, and chronic disease treatment. India accounted for nearly 24% of regional catheter utilization because of increasing hospitalization rates and rising outpatient infusion therapy services. More than 48% of private hospitals in India adopted safety IV catheter technologies between 2023 and 2025.

Middle East & Africa

Middle East & Africa accounted for approximately 6% of the global Peripheral IV Catheters Market Share in 2025 because of increasing healthcare investments, hospital infrastructure development, and rising emergency care utilization. Saudi Arabia, the United Arab Emirates, and South Africa collectively represented nearly 64% of regional peripheral IV catheter demand. Around 46% of newly established hospitals in the Gulf region integrated safety-engineered peripheral IV catheter systems to improve infection prevention and patient safety standards.

Saudi Arabia accounted for approximately 28% of regional catheter utilization because of rising hospitalization rates and healthcare modernization initiatives. The United Arab Emirates represented nearly 19% of regional demand through expansion of ambulatory care facilities and outpatient infusion therapy services. South Africa contributed approximately 17% of regional peripheral IV catheter consumption because of increasing emergency treatment procedures and chronic disease management programs.

List of Top Peripheral IV Catheters Companies

• Tangent Medical Technologies
• Smith Medical
• Braun Melsungen
• R. Bard
• Becton, Dickinson and Company
• Argon Medical Devices
• Terumo Corporation
• Vygon SA
• Teleflex
• Vigmed AB

Investment Analysis and Opportunities

The Peripheral IV Catheters Market Analysis highlights increasing investments in safety-engineered catheter systems, antimicrobial technologies, and outpatient infusion therapy infrastructure. More than 53% of healthcare procurement investments during 2025 focused on upgrading conventional peripheral IV catheters to safety-based systems with passive needle protection mechanisms. Around 41% of hospital modernization projects integrated advanced intravenous therapy equipment and infection prevention technologies.Home healthcare and outpatient infusion services represented major investment opportunities. Approximately 36% of infusion therapy providers expanded home-based intravenous treatment capabilities between 2023 and 2025. Healthcare facilities also increased investment in catheter stabilization and securement technologies, with nearly 29% of hospitals implementing advanced catheter fixation systems to reduce accidental dislodgement and therapy interruptions.

Technological innovation remained a significant investment area. Around 33% of medical device manufacturers increased spending on antimicrobial-coated catheter development and needle-free IV access systems. In North America and Europe, approximately 24% of healthcare institutions integrated digital catheter tracking and infusion monitoring technologies to improve patient safety and reduce catheter-related complications.Asia-Pacific emerged as a major investment destination because of expanding healthcare infrastructure and rising patient admissions. Approximately 38% of newly established hospitals across India, China, and Southeast Asia procured safety peripheral IV catheter systems during 2025. The Peripheral IV Catheters Market Opportunities continue expanding through healthcare digitization, outpatient treatment growth, and infection prevention initiatives worldwide.

New Product Development

The Peripheral IV Catheters Market Trends indicate rapid innovation in antimicrobial-coated catheters, needle-free access systems, and advanced stabilization technologies. More than 44% of newly launched peripheral IV catheter products during 2025 included passive safety activation mechanisms to reduce needlestick injuries among healthcare workers. Antimicrobial-coated catheter systems reduced catheter-related bloodstream infection risks by approximately 21% in long-duration intravenous therapy procedures.Approximately 39% of medical device manufacturers introduced closed-system peripheral IV catheters with integrated blood control features to minimize contamination and improve procedural efficiency. In critical care settings, around 31% of healthcare providers adopted advanced catheter stabilization devices capable of reducing accidental catheter dislodgement by nearly 18%.

Portable infusion support technologies also evolved significantly. Around 27% of outpatient infusion therapy systems integrated lightweight peripheral IV catheter accessories to improve patient mobility and treatment comfort. Ultrasound-compatible catheter systems gained strong adoption across emergency departments, with nearly 22% of hospitals implementing advanced insertion guidance technologies between 2023 and 2025.Manufacturers also focused on eco-friendly and biocompatible catheter materials. Approximately 18% of newly developed peripheral IV catheters utilized latex-free and low-irritation polymer materials to reduce patient sensitivity and improve long-term treatment compatibility. The Peripheral IV Catheters Industry Analysis identifies infection prevention technologies, passive safety systems, and outpatient-friendly catheter solutions as major product innovation trends during 2025.

Five Recent Developments (2023-2025)

1. In 2025, Becton, Dickinson and Company expanded production of safety peripheral IV catheters with integrated blood control technology, improving healthcare worker exposure prevention by approximately 26%.
2. During 2024, B. Braun Melsungen introduced antimicrobial-coated peripheral IV catheter systems capable of reducing bacterial colonization rates by nearly 22% in extended infusion therapy applications.
3. In 2025, multiple hospitals across North America adopted ultrasound-guided peripheral IV insertion systems, increasing successful first-attempt catheter placement rates by approximately 19%.
4. During 2024, outpatient infusion therapy centers expanded home healthcare catheter programs by nearly 28%, increasing demand for portable and securement-enhanced peripheral IV catheter technologies.
5. In 2025, healthcare institutions across Europe upgraded needle-free IV access systems, reducing accidental needlestick injuries among healthcare workers by approximately 24%.

Report Coverage of Peripheral IV Catheters Market

The Peripheral IV Catheters Market Report provides comprehensive analysis of market trends, healthcare utilization patterns, technological advancements, and competitive developments across hospitals, ambulatory surgical centers, clinics, home healthcare, and emergency medical services. The report evaluates catheter utilization volumes, infection prevention technologies, safety catheter adoption trends, and healthcare infrastructure developments across more than 65 countries and over 150 healthcare device manufacturers.The report includes segmentation analysis by type, covering safety peripheral IV catheters and conventional peripheral IV catheters. Safety catheters accounted for approximately 62% of global market demand in 2025 because of increasing occupational safety regulations and infection prevention initiatives. Conventional catheters represented nearly 38% share due to continued utilization across cost-sensitive healthcare systems and emergency treatment applications.

Application analysis within the Peripheral IV Catheters Market Research Report covers hospitals, ambulatory surgical centers, clinics, home healthcare, and specialty healthcare facilities. Hospitals represented approximately 58% of total peripheral IV catheter utilization, while clinics and home healthcare each accounted for nearly 14% of market demand during 2025.Regional analysis includes North America, Europe, Asia-Pacific, and Middle East & Africa. North America maintained approximately 38% share of global peripheral IV catheter utilization because of advanced hospital infrastructure and widespread adoption of safety catheter technologies. Europe represented nearly 27% of market demand through strong infection prevention regulations and outpatient healthcare expansion. Asia-Pacific accounted for approximately 29% share because of increasing healthcare investments and rising patient admissions.